Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01SRS
|
|||
| Former ID |
DNC004986
|
|||
| Drug Name |
3-Methyl-7-nitro-1,2,3,4-tetrahydro-isoquinoline
|
|||
| Synonyms |
CHEMBL59719; 3-methyl-7-nitro-1,2,3,4-tetrahydroisoquinoline; 3-Methyl-7-nitro-1,2,3,4-tetrahydro-isoquinoline; SCHEMBL7512740; Isoquinoline, 1,2,3,4-tetrahydro-3-methyl-7-nitro-; OTVSEAHLIUCIKT-UHFFFAOYSA-N; BDBM50077543
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H12N2O2
|
|||
| Canonical SMILES |
CC1CC2=C(CN1)C=C(C=C2)[N+](=O)[O-]
|
|||
| InChI |
1S/C10H12N2O2/c1-7-4-8-2-3-10(12(13)14)5-9(8)6-11-7/h2-3,5,7,11H,4,6H2,1H3
|
|||
| InChIKey |
OTVSEAHLIUCIKT-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Adrenergic receptor alpha-2A (ADRA2A) | Target Info | Inhibitor | [1] |
| KEGG Pathway | cGMP-PKG signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| Panther Pathway | Alpha adrenergic receptor signaling pathway | |||
| Reactome | Adrenoceptors | |||
| Adrenaline signalling through Alpha-2 adrenergic receptor | ||||
| Adrenaline,noradrenaline inhibits insulin secretion | ||||
| G alpha (i) signalling events | ||||
| G alpha (z) signalling events | ||||
| Surfactant metabolism | ||||
| WikiPathways | Monoamine GPCRs | |||
| GPCRs, Class A Rhodopsin-like | ||||
| Platelet Aggregation (Plug Formation) | ||||
| Integration of energy metabolism | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoqui... Bioorg Med Chem Lett. 2005 Feb 15;15(4):1143-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.